the clinical investigations , following performance of neuroadenolysis , indicate suppressed pituitary function , significant increase of acth , thyrotropin-releasing hormone and vasopressin in the cerebrospinal fluid ( csf ) , delay of long latencies in somatosensory evoked potential and increased pain threshold of c-fibres .
C0032002
pituitary
C0040162
thyrotropin-releasing hormone